PetMed Express (NASDAQ: PETS) reported Q2 EPS of $0.24, $0.02 worse than the analyst estimate of $0.26. Revenue for the quarter came in at $60.79 million versus the consensus estimate of $58.7 million.

For earnings history and earnings-related data on PetMed Express (PETS) click here.